New Test to Simultaneously Detect 22 Respiratory Pathogens

AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced the launch of the NxTAG™ Respiratory Pathogen Panel (RUO). The NxTAG Respiratory Pathogen Panel is the only respiratory assay that enables laboratories to both simultaneously detect 22 respiratory pathogens in a single closed tube system and accommodate the higher throughput required to respond to seasonal changes [...]

UK National Graphene Institute Selects Bruker as Official Partner

BILLERICA, Mass. -- Bruker Corporation (NASDAQ: BRKR) today announced an official partnership with the University of Manchester’s National Graphene Institute (NGI), joining a select list of industrial collaborators. This partnership follows NGI’s purchase of two additional atomic force microscopes (AFMs) from Bruker, a Dimension FastScan® and a Dimension Icon®. These systems join five other Bruker [...]

New Alliance Between Microfluidics And Particle Sciences Expands Reach Of Microfluidizer® Technology

Westwood, MA — Microfluidics, exclusive global creator of Microfluidizer® high shear fluid processors, is now partnering with Particle Sciences, Inc., a leading contract development and manufacturing organization (CDMO). This new alliance is designed to give the companies more ways to serve their clients with complex formulation development as well as lab support testing services in [...]

Microfluidics Releases New Digitally Controlled Lab Unit For Small Sample Material Processing

Westwood, MA — Microfluidics International Corporation, the company known for their Microfluidizer® high shear fluid processors, has just launched the new LM10 Microfluidizer®, a digitally controlled lab unit for small sample material processing. This new tool is able to convert pressure energy into shear and impact forces more efficiently, creating targeted size reduction at lower [...]

Artel Adds Comprehensive Feature Set to ArtelWare™ Software for Liquid Handler Management

Westbrook, Maine -– Artel, the leader in liquid handling quality assurance, announces ArtelWare v1.3, with a new feature set that extends the company’s rounding out of the comprehensive capabilities of this software for the its MVS® Multichannel Verification System. Artel has been regularly adding functionality to ArtelWare since its introduction at SLAS 2014. This latest [...]

Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System

BILLERICA, Mass.-- Bruker (NASDAQ: BRKR) today announced that it has received 510(k) clearance from the US Food and Drug Administration for library and methods expansion for the MALDI Biotyper CA System, sold in the United States for clinical microbiology. In November 2013, Bruker received FDA 510(k) clearance for a first claim for the MALDI Biotyper [...]

Schrödinger Announces Collaboration with Sanofi to Provide Computational Resources in Support of Its Drug Discovery Programs

NEW YORK, NY -– Schrödinger, Inc. announced today that it has entered into a collaboration with Sanofi, in which Schrödinger will provide comprehensive computational drug design support, from target analysis and validation to lead identification and lead optimization, for as many as ten drug discovery programs. Schrödinger could receive up to $120 million under the [...]

NODALITY LAUNCHES PATHPRO™ CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PANELS BASED ON LEADING SINGLE CELL NETWORK PROFILING (SCNP™) PLATFORM TO ENHANCE PHARMACEUTICAL R&D

South San Francisco, California -- Nodality, Inc., which is focused on solving drug development challenges, announced today the availability of its new PathPro™ Chronic Lymphocytic Leukemia (CLL) panels. These panels are designed to characterize cell pathways associated with disease signaling at the single cell level and to analyze the activity of therapeutics commonly used or [...]

Caribou Biosciences Raises $11 Million in Series A Funding

BERKELEY, Calif. -- Caribou Biosciences, a developer of CRISPR-Cas9 technologies for precision cell engineering, today announced that it has closed an $11 million Series A financing round. Investors include Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and an undisclosed strategic partner. In addition, Dr. Jennifer Doudna, Investigator, Howard Hughes Medical Institute, Professor, U.C. [...]

Certara Launches its Cardiac Safety Simulator V2.0

PRINCETON, NJ –– Certara®, the global biosimulation technology-enabled consultancy, today announced the launch of version 2.0 of its Cardiac Safety Simulator (CSS), which has become a standalone product for the first time. CSS is currently being used by several leading pharma companies, two of which collaborated with Certara on its development. The subject area is [...]

Access IBO on Knowledge Center